No change of infliximab levels in stored blood for preoperative autologous blood donation: A preliminary report

Modern Rheumatology

Volumn 15, Issue 4, 2005, Pages 302-304

  Nishimura, Keita ^a   Wakimoto, Nobuhiro ^a   Sasahara, Jun ^a   Yanagisawa, Chiaki ^a   Eda, Fukiko ^a   Nishino, Jinju ^a   Tomiyama, Hidekazu ^a   Matsushita, Takashi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Infliximab; Preoperative autologous blood donation (PABD); Rheumatoid arthritis (RA); Total joint arthroplasty

Indexed keywords

INFLIXIMAB; METHOTREXATE;

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD STORAGE; CASE REPORT; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PHLEBOTOMY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 24144478997     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-005-0404-z     Document Type: Article

References (5)

1. RN Maini FC Breedveld JR Kalden JS Smolen D Davis JD Macfarlane et al. 1998 Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1552-63 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W 9751087
2. A Markham HM Lamb 2000 Infliximab: A review of its use in the management of rheumatoid arthritis Drugs 59 1341-59 10882166
3. RN Maini MJ Elliott A Long-Fox M Feldmann JR Kalden C Antonio 1995 Clinical response of rheumatoid arthritis (RA) to anti-TNFα (cA2) monoclonal antibody (mAb) is related to administered dose and persistence of circulating antibody [abstract no 200] Arthritis Rheum 38 Suppl S186
4. SB Hanauer 1999 Safety of infliximab in clinical trials Aliment Pharmacol Ther 13 Suppl 4 16-22 10.1046/j.1365-2036.1999.00027.x 10597335
5. C Bibbo JW Goldberg 2004 Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy Foot Ankle Int 25 331-5 15134615